High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic

Paula C. Goldenberg, Betsy J. Adler, Ashley Parrott, Julia Anixt, Karen Mason, Jannel Phillips, David S. Cooper, Stephanie Ware, Bradley S. Marino

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: There is a known high prevalence of genetic and clinical syndrome diagnoses in the paediatric cardiac population. These disorders often have multisystem effects, which may have an important impact on neurodevelopmental outcomes. Taken together, these facts suggest that patients and families may benefit from consultation by genetic specialists in a cardiac neurodevelopmental clinic. Objective: This study assessed the burden of genetic disorders and utility of genetics evaluation in a cardiac neurodevelopmental clinic. Methods: A retrospective chart review was conducted of patients evaluated in a cardiac neurodevelopmental clinic from 6 December, 2011 to 16 April, 2013. All patients were seen by a cardiovascular geneticist with genetic counselling support. Results: A total of 214 patients were included in this study; 64 of these patients had a pre-existing genetic or syndromic diagnosis. Following genetics evaluation, an additional 19 were given a new clinical or laboratory-confirmed genetic diagnosis including environmental such as teratogenic exposures, malformation associations, chromosomal disorders, and single-gene disorders. Genetic testing was recommended for 112 patients; radiological imaging to screen for congenital anomalies for 17 patients; subspecialist medical referrals for 73 patients; and non-genetic clinical laboratory testing for 14 patients. Syndrome-specific guidelines were available and followed for 25 patients with known diagnosis. American Academy of Pediatrics Red Book asplenia guideline recommendations were given for five heterotaxy patients, and family-based cardiac screening was recommended for 23 families affected by left ventricular outflow tract obstruction. Conclusion: Genetics involvement in a cardiac neurodevelopmental clinic is helpful in identifying new unifying diagnoses and providing syndrome-specific care, which may impact the patient’s overall health status and neurodevelopmental outcome.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalCardiology in the Young
DOIs
StateAccepted/In press - Sep 19 2016

Fingerprint

Referral and Consultation
Chromosome Disorders
Guidelines
Pediatrics
Ventricular Outflow Obstruction
Inborn Genetic Diseases
Genetic Counseling
Genetic Testing
Health Status
Population
Genes

Keywords

  • development
  • Genetic evaluation
  • heart defects
  • medical

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

Goldenberg, P. C., Adler, B. J., Parrott, A., Anixt, J., Mason, K., Phillips, J., ... Marino, B. S. (Accepted/In press). High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic. Cardiology in the Young, 1-8. https://doi.org/10.1017/S104795111600072X

High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic. / Goldenberg, Paula C.; Adler, Betsy J.; Parrott, Ashley; Anixt, Julia; Mason, Karen; Phillips, Jannel; Cooper, David S.; Ware, Stephanie; Marino, Bradley S.

In: Cardiology in the Young, 19.09.2016, p. 1-8.

Research output: Contribution to journalArticle

Goldenberg, PC, Adler, BJ, Parrott, A, Anixt, J, Mason, K, Phillips, J, Cooper, DS, Ware, S & Marino, BS 2016, 'High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic', Cardiology in the Young, pp. 1-8. https://doi.org/10.1017/S104795111600072X
Goldenberg, Paula C. ; Adler, Betsy J. ; Parrott, Ashley ; Anixt, Julia ; Mason, Karen ; Phillips, Jannel ; Cooper, David S. ; Ware, Stephanie ; Marino, Bradley S. / High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic. In: Cardiology in the Young. 2016 ; pp. 1-8.
@article{4eb81269df8d4842bbfe7c967a5d7352,
title = "High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic",
abstract = "Background: There is a known high prevalence of genetic and clinical syndrome diagnoses in the paediatric cardiac population. These disorders often have multisystem effects, which may have an important impact on neurodevelopmental outcomes. Taken together, these facts suggest that patients and families may benefit from consultation by genetic specialists in a cardiac neurodevelopmental clinic. Objective: This study assessed the burden of genetic disorders and utility of genetics evaluation in a cardiac neurodevelopmental clinic. Methods: A retrospective chart review was conducted of patients evaluated in a cardiac neurodevelopmental clinic from 6 December, 2011 to 16 April, 2013. All patients were seen by a cardiovascular geneticist with genetic counselling support. Results: A total of 214 patients were included in this study; 64 of these patients had a pre-existing genetic or syndromic diagnosis. Following genetics evaluation, an additional 19 were given a new clinical or laboratory-confirmed genetic diagnosis including environmental such as teratogenic exposures, malformation associations, chromosomal disorders, and single-gene disorders. Genetic testing was recommended for 112 patients; radiological imaging to screen for congenital anomalies for 17 patients; subspecialist medical referrals for 73 patients; and non-genetic clinical laboratory testing for 14 patients. Syndrome-specific guidelines were available and followed for 25 patients with known diagnosis. American Academy of Pediatrics Red Book asplenia guideline recommendations were given for five heterotaxy patients, and family-based cardiac screening was recommended for 23 families affected by left ventricular outflow tract obstruction. Conclusion: Genetics involvement in a cardiac neurodevelopmental clinic is helpful in identifying new unifying diagnoses and providing syndrome-specific care, which may impact the patient’s overall health status and neurodevelopmental outcome.",
keywords = "development, Genetic evaluation, heart defects, medical",
author = "Goldenberg, {Paula C.} and Adler, {Betsy J.} and Ashley Parrott and Julia Anixt and Karen Mason and Jannel Phillips and Cooper, {David S.} and Stephanie Ware and Marino, {Bradley S.}",
year = "2016",
month = "9",
day = "19",
doi = "10.1017/S104795111600072X",
language = "English (US)",
pages = "1--8",
journal = "Cardiology in the Young",
issn = "1047-9511",
publisher = "Cambridge University Press",

}

TY - JOUR

T1 - High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic

AU - Goldenberg, Paula C.

AU - Adler, Betsy J.

AU - Parrott, Ashley

AU - Anixt, Julia

AU - Mason, Karen

AU - Phillips, Jannel

AU - Cooper, David S.

AU - Ware, Stephanie

AU - Marino, Bradley S.

PY - 2016/9/19

Y1 - 2016/9/19

N2 - Background: There is a known high prevalence of genetic and clinical syndrome diagnoses in the paediatric cardiac population. These disorders often have multisystem effects, which may have an important impact on neurodevelopmental outcomes. Taken together, these facts suggest that patients and families may benefit from consultation by genetic specialists in a cardiac neurodevelopmental clinic. Objective: This study assessed the burden of genetic disorders and utility of genetics evaluation in a cardiac neurodevelopmental clinic. Methods: A retrospective chart review was conducted of patients evaluated in a cardiac neurodevelopmental clinic from 6 December, 2011 to 16 April, 2013. All patients were seen by a cardiovascular geneticist with genetic counselling support. Results: A total of 214 patients were included in this study; 64 of these patients had a pre-existing genetic or syndromic diagnosis. Following genetics evaluation, an additional 19 were given a new clinical or laboratory-confirmed genetic diagnosis including environmental such as teratogenic exposures, malformation associations, chromosomal disorders, and single-gene disorders. Genetic testing was recommended for 112 patients; radiological imaging to screen for congenital anomalies for 17 patients; subspecialist medical referrals for 73 patients; and non-genetic clinical laboratory testing for 14 patients. Syndrome-specific guidelines were available and followed for 25 patients with known diagnosis. American Academy of Pediatrics Red Book asplenia guideline recommendations were given for five heterotaxy patients, and family-based cardiac screening was recommended for 23 families affected by left ventricular outflow tract obstruction. Conclusion: Genetics involvement in a cardiac neurodevelopmental clinic is helpful in identifying new unifying diagnoses and providing syndrome-specific care, which may impact the patient’s overall health status and neurodevelopmental outcome.

AB - Background: There is a known high prevalence of genetic and clinical syndrome diagnoses in the paediatric cardiac population. These disorders often have multisystem effects, which may have an important impact on neurodevelopmental outcomes. Taken together, these facts suggest that patients and families may benefit from consultation by genetic specialists in a cardiac neurodevelopmental clinic. Objective: This study assessed the burden of genetic disorders and utility of genetics evaluation in a cardiac neurodevelopmental clinic. Methods: A retrospective chart review was conducted of patients evaluated in a cardiac neurodevelopmental clinic from 6 December, 2011 to 16 April, 2013. All patients were seen by a cardiovascular geneticist with genetic counselling support. Results: A total of 214 patients were included in this study; 64 of these patients had a pre-existing genetic or syndromic diagnosis. Following genetics evaluation, an additional 19 were given a new clinical or laboratory-confirmed genetic diagnosis including environmental such as teratogenic exposures, malformation associations, chromosomal disorders, and single-gene disorders. Genetic testing was recommended for 112 patients; radiological imaging to screen for congenital anomalies for 17 patients; subspecialist medical referrals for 73 patients; and non-genetic clinical laboratory testing for 14 patients. Syndrome-specific guidelines were available and followed for 25 patients with known diagnosis. American Academy of Pediatrics Red Book asplenia guideline recommendations were given for five heterotaxy patients, and family-based cardiac screening was recommended for 23 families affected by left ventricular outflow tract obstruction. Conclusion: Genetics involvement in a cardiac neurodevelopmental clinic is helpful in identifying new unifying diagnoses and providing syndrome-specific care, which may impact the patient’s overall health status and neurodevelopmental outcome.

KW - development

KW - Genetic evaluation

KW - heart defects

KW - medical

UR - http://www.scopus.com/inward/record.url?scp=84988411842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988411842&partnerID=8YFLogxK

U2 - 10.1017/S104795111600072X

DO - 10.1017/S104795111600072X

M3 - Article

SP - 1

EP - 8

JO - Cardiology in the Young

JF - Cardiology in the Young

SN - 1047-9511

ER -